Delgocitinib

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 138 publications

Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel.

Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel.

Journal: Journal of drugs in dermatology : JDD
Published: March 11, 2026

Successful Treatment of Granulomatous Dermatitis With Topical Delgocitinib.

Successful Treatment of Granulomatous Dermatitis With Topical Delgocitinib.

Journal: JAMA dermatology
Published: March 11, 2026

Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.

Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.

Journal: Journal of drugs in dermatology : JDD
Published: March 04, 2026

Drugs for atopic dermatitis.

Drugs for atopic dermatitis.

Journal: The Medical letter on drugs and therapeutics
Published: February 23, 2026

The Patient Journey: From Diagnosis to Therapeutic Management of Chronic Hand Eczema.

The Patient Journey: From Diagnosis to Therapeutic Management of Chronic Hand Eczema.

Journal: Dermatitis : contact, atopic, occupational, drug
Published: February 06, 2026

Properties of FDA-approved small molecule protein kinase inhibitors: A 2026 update.

Properties of FDA-approved small molecule protein kinase inhibitors: A 2026 update.

Journal: Pharmacological research
Published: January 20, 2026

Efficacy and Safety of Topical Delgocitinib for Chronic Hand Eczema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Efficacy and Safety of Topical Delgocitinib for Chronic Hand Eczema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal: Experimental dermatology
Published: January 04, 2026

A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen-Ultraviolet A in Chronic Hand Eczema.

A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen-Ultraviolet A in Chronic Hand Eczema.

Journal: Dermatology and therapy
Published: December 19, 2025

Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials.

Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials.

Journal: American journal of clinical dermatology
Published: November 01, 2025

Delgocitinib Cream Reduces Itch and Pain in Moderate to Severe Chronic Hand Eczema: Phase 3 DELTA 1 and 2 Pooled Analyses.

Delgocitinib Cream Reduces Itch and Pain in Moderate to Severe Chronic Hand Eczema: Phase 3 DELTA 1 and 2 Pooled Analyses.

Journal: Dermatology and therapy
Published: October 22, 2025

Effect of Delgocitinib Cream on Health-Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema.

Effect of Delgocitinib Cream on Health-Related Quality of Life in Patients With Moderate to Severe Chronic Hand Eczema.

Journal: Contact dermatitis
Published: October 08, 2025

Delgocitinib cream (Anzupgo) for chronic hand eczema.

Delgocitinib cream (Anzupgo) for chronic hand eczema.

Journal: The Medical letter on drugs and therapeutics
Published: October 08, 2025
Showing 1-12 of 138

Last Updated: 04/28/2026